Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT00334399
Collaborator
(none)
13
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Type 2 diabetic patients treated with Biguanide
-
Criteria for postprandial plasma glucose and HbA1c are met
Exclusion Criteria:
-
Type 1 diabetes
-
Patients treated with other antidiabetic drugs or Insulin
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Aichi | Japan | |||
| 2 | Chiba | Japan | |||
| 3 | Fukuoka | Japan | |||
| 4 | Gifu | Japan | |||
| 5 | Gunma | Japan | |||
| 6 | Hokkaido | Japan | |||
| 7 | Ibaragi | Japan | |||
| 8 | Kanagawa | Japan | |||
| 9 | Kumamoto | Japan | |||
| 10 | Miyazaki | Japan | |||
| 11 | Osaka | Japan | |||
| 12 | Saitama | Japan | |||
| 13 | Tochigi | Japan |
Sponsors and Collaborators
- Sanwa Kagaku Kenkyusho Co., Ltd.
Investigators
- Study Director: Clinical Study Group, Clinical Development Dept., Sanwa Kagaku Kenkyusho Co., Ltd.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00334399
Other Study ID Numbers:
- MG1008
First Posted:
Jun 7, 2006
Last Update Posted:
Oct 10, 2008
Last Verified:
Oct 1, 2008
Keywords provided by ,
,
Additional relevant MeSH terms: